Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Genmark Diagnostics (GNMK)

Genmark Diagnostics (GNMK)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Relatively Good Performance Detected in Shares of Genmark Diagnost in the Health Care Equipment Industry (GNMK , OXFD , IDXX , MASI , DXCM )

Here are the top 5 stocks in the Health Care Equipment industry ranked by performance. We compiled the trading activity from yesterday and then analyzed the industry looking for stocks that were outperforming....

OXFD : 14.00 (+1.01%)
GNMK : 6.49 (+1.09%)
IDXX : 275.41 (+0.86%)
GenMark Diagnostics (GNMK) Reports Q2 Loss, Tops Revenue Estimates

GenMark Diagnostics (GNMK) delivered earnings and revenue surprises of -9.52% and 2.56%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock?

GNMK : 6.49 (+1.09%)
GenMark Diagnostics Reports Second Quarter 2019 Results

GenMark Diagnostics, Inc. (Nasdaq: GNMK), a leading provider of automated, multiplex molecular diagnostic testing systems, today announced financial results for the quarter ended June 30, 2019.

GNMK : 6.49 (+1.09%)
GenMark Diagnostics to Participate in the Canaccord Genuity Growth Conference

GenMark Diagnostics, Inc. (NASDAQ:GNMK), a leading provider of automated, multiplex molecular diagnostic testing systems, today announced that the company plans to participate in the upcoming Canaccord...

GNMK : 6.49 (+1.09%)
GenMark Diagnostics Schedules Second Quarter 2019 Financial Results Conference Call for August 5, 2019

GenMark Diagnostics, Inc. (NASDAQ: GNMK) today announced that it plans to release its second quarter earnings results after market close on Monday, August 5, 2019. Management will hold a conference call...

GNMK : 6.49 (+1.09%)
Will GenMark Diagnostics (GNMK) Report Negative Q2 Earnings? What You Should Know

GenMark Diagnostics (GNMK) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

GNMK : 6.49 (+1.09%)
Cardiovascular S has the Best Relative Performance in the Health Care Equipment Industry (CSII , GNMK , ANGO , DXCM , NUVA )

We looked at the Health Care Equipment industry and measured relative performance to find the top stocks. Relative outperformance is a bullish sign of underlying fundamental and technical strength. We...

GNMK : 6.49 (+1.09%)
ANGO : 18.97 (+1.17%)
CSII : 48.30 (+2.74%)
Best Relative Performance in the Health Care Equipment Industry Detected in Shares of Dexcom (DXCM , IART , GNMK , TNDM, BSX )

Below are the top five companies in the Health Care Equipment industry as measured by relative performance. This analysis was compiled based on yesterday's trading activity as we search for stocks that...

GNMK : 6.49 (+1.09%)
TNDM : 58.76 (+2.89%)
IART : 61.02 (+1.65%)
DXCM : 163.68 (+3.25%)
GenMark Diagnostics to Participate in Upcoming Investor Conferences

GenMark Diagnostics, Inc. (NASDAQ:GNMK), a leading provider of automated, multiplex molecular diagnostic testing systems, today announced that the company plans to participate in three upcoming investor...

GNMK : 6.49 (+1.09%)
Genmark Diagnost Has Returned 51.0% Since SmarTrend Recommendation (GNMK)

SmarTrend identified an Uptrend for Genmark Diagnost (NASDAQ:GNMK) on January 3rd, 2019 at $4.82. In approximately 4 months, Genmark Diagnost has returned 50.99% as of today's recent price of $7.27.

GNMK : 6.49 (+1.09%)
Genmark Diagnost Shares Up 61.2% Since SmarTrend's Buy Recommendation (GNMK)

SmarTrend identified an Uptrend for Genmark Diagnost (NASDAQ:GNMK) on January 3rd, 2019 at $4.82. In approximately 4 months, Genmark Diagnost has returned 61.16% as of today's recent price of $7.76.

GNMK : 6.49 (+1.09%)
GenMark Diagnostics to Present at the Bank of America Merrill Lynch Health Care Conference

GenMark Diagnostics, Inc. (NASDAQ: GNMK), a leading provider of automated, multiplex molecular diagnostic testing systems, today announced that the company plans to participate in the Bank of America Merrill...

GNMK : 6.49 (+1.09%)
GenMark Diagnostics Reports First Quarter 2019 Results

GenMark Diagnostics, Inc. (Nasdaq: GNMK), a leading provider of automated, multiplex molecular diagnostic testing systems, today announced financial results for the quarter ended March 31, 2019.

GNMK : 6.49 (+1.09%)
GenMark Diagnostics Expands Commercial Team

GenMark Diagnostics, Inc. (NASDAQ:GNMK), a leading provider of automated, multiplex molecular diagnostic testing systems, today announced that it has expanded its commercial team in North America with...

GNMK : 6.49 (+1.09%)
GenMark Diagnostics Schedules First Quarter 2019 Financial Results Conference Call for April 30, 2019

GenMark Diagnostics, Inc. (NASDAQ: GNMK) today announced that it plans to release its first quarter earnings results after market close on Tuesday, April 30, 2019. Management will hold a conference call...

GNMK : 6.49 (+1.09%)
GenMark Diagnostics Receives FDA 510(k) Market Clearance for its ePlex Blood Culture Identification Gram-Negative Panel

GenMark Diagnostics, Inc. (NASDAQ:GNMK), a leading provider of automated, multiplex molecular diagnostic testing systems, today announced that it has received FDA 510(k) market clearance from the U.S....

GNMK : 6.49 (+1.09%)
Market Trends Toward New Normal in ZTO Express (Cayman), ProPetro Holding, Social Reality, The Habit Restaurants, GenMark Diagnostics, and Power Integrations -- Emerging Consolidated Expectations, Analyst Ratings

In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of ZTO Express (Cayman) Inc. (NYSE:ZTO),...

SRAX : 3.49 (+2.35%)
SCRI : 1.3000 (unch)
ZTO : 19.38 (+1.47%)
GNMK : 6.49 (+1.09%)
POWI : 86.91 (+3.56%)
HABT : 8.90 (+5.33%)
PUMP : 11.34 (+0.62%)
Genmark Diagnost Has Returned 48.3% Since SmarTrend Recommendation (GNMK)

SmarTrend identified an Uptrend for Genmark Diagnost (NASDAQ:GNMK) on January 3rd, 2019 at $4.82. In approximately 3 months, Genmark Diagnost has returned 48.29% as of today's recent price of $7.14.

GNMK : 6.49 (+1.09%)
Uptrend Call Working As Genmark Diagnost Stock Rises 48.1% (GNMK)

SmarTrend identified an Uptrend for Genmark Diagnost (NASDAQ:GNMK) on January 3rd, 2019 at $4.82. In approximately 3 months, Genmark Diagnost has returned 48.08% as of today's recent price of $7.13.

GNMK : 6.49 (+1.09%)
Genmark Diagnost Has Returned 53.1% Since SmarTrend Recommendation (GNMK)

SmarTrend identified an Uptrend for Genmark Diagnost (NASDAQ:GNMK) on January 3rd, 2019 at $4.82. In approximately 3 months, Genmark Diagnost has returned 53.06% as of today's recent price of $7.37.

GNMK : 6.49 (+1.09%)

Van Meerten Stock Picks

AMD - Volume Leader
The Volume Leader today is the semiconductor company Advanced Micro Devices (AMD).
AMD +1.51
Jim Van Meerten uses Barchart's tools to offer daily stock picks and recommendations. His portfolios have been honored by Marketocracy and Morningstar.

InsideFutures Commentary

InsideFutures is a twice weekly newsletter that features a selection of the latest and best commodities commentary appearing on Barchart.com. Delivered every Wednesday and Friday morning to your inbox.

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar